Generex Awarded New Patent in Europe
Company Expands Patent Portfolio in Several European Countries
19-Dec-2008
- USA
"We are pleased that we have been granted this European patent," said Rose Perri, the Company's Chief Operating Officer as we plan ahead for our regulatory submissions with the centralized authorities in Europe.
Generex currently holds an aggregate of 142 patents worldwide (21 of which are United States patents) and has an aggregate of 120 patent applications pending in various jurisdictions.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.